Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
12/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $21,859 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7,272 | $60 | $60 | – |
| Gross Profit | $14,587 | -$60 | -$60 | – |
| % Margin | 66.7% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | – |
| G&A Expenses | $0 | $1,907 | $410 | – |
| SG&A Expenses | $6,670 | $1,907 | $410 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $2,749 | $200 | $60 | – |
| Operating Expenses | $9,419 | $2,107 | $410 | – |
| Operating Income | -$2,103 | -$343 | -$462 | – |
| % Margin | -9.6% | – | – | – |
| Other Income/Exp. Net | -$6,692 | $1,884 | $48 | – |
| Pre-Tax Income | -$8,795 | -$343 | -$414 | – |
| Tax Expense | $0 | $58 | -$56 | – |
| Net Income | -$8,795 | -$400 | -$358 | – |
| % Margin | -40.2% | – | – | – |
| EPS | -756.01 | -0.17 | -0.041 | – |
| % Growth | -444,611.8% | -314.6% | – | – |
| EPS Diluted | -0.76 | -0.04 | -0.041 | – |
| Weighted Avg Shares Out | 11,635 | 2,313 | 8,741 | – |
| Weighted Avg Shares Out Dil | 11,635 | 10,004 | 8,741 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $106 | $0 | $0 | – |
| Interest Expense | -$6,933 | $0 | $8 | – |
| Depreciation & Amortization | $0 | -$3,649 | $56 | – |
| EBITDA | -$2,103 | -$3,992 | -$350 | – |
| % Margin | -9.6% | – | – | – |